Physician profile
William J Morris
NPI 1801900956
$3,401.68
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,154 · 2020: $1,097 · 2021: $1,092 · 2023: $40.18 · 2024: $18.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $692.29 | 2019-2021 | |
| Braintree Laboratories, INC. | $544.01 | 2019-2021 | |
| Janssen Biotech, INC. | $469.37 | 2019-2021 | |
| Abbvie INC. | $388.40 | 2019-2021 | |
| Pfizer INC. | $339.15 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $306.82 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $138.63 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.16 | 2019-2020 | |
| Allergan, INC. | $59.59 | 2019-2020 | |
| Qol Medical, LLC | $56.85 | 2021 | |
| Abbott Laboratories | $43.90 | 2020-2023 | Freestyle Libre 3 |
| Astellas Pharma US INC | $36.66 | 2023-2024 | Veozah |
| Ferring Pharmaceuticals INC. | $35.93 | 2020-2021 | |
| Shire North American Group INC | $35.90 | 2019 | |
| Glaxosmithkline, LLC. | $26.77 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $26.76 | 2020 | |
| Merck Sharp & Dohme LLC | $16.42 | 2021 | |
| Alfasigma USA, INC. | $15.77 | 2020 | |
| Novo Nordisk INC | $14.34 | 2021 | |
| Shionogi INC | $12.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.69 | 2020 | |
| Micro-Tech Endoscopy USA, INC. | $5.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.